Search hospitals > Ontario > TORONTO

University Health Network

Claim this profile
TORONTO, Ontario M5G 2C4
Global Leader in Prostate Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Depression
Conducts research for Breast Cancer
541 reported clinical trials
60 medical researchers
Photo of University Health Network in TORONTOPhoto of University Health Network in TORONTOPhoto of University Health Network in TORONTO

Summary

University Health Network is a medical facility located in TORONTO, Ontario. This center is recognized for care of Prostate Cancer, Cancer, Lung Cancer, Depression, Breast Cancer and other specialties. University Health Network is involved with conducting 541 clinical trials across 705 conditions. There are 60 research doctors associated with this hospital, such as Lillian Siu, MD, Marcus Butler, Anna Spreafico, MD PhD, and Peter Chung, MD.

Area of expertise

1Prostate Cancer
Global Leader
University Health Network has run 33 trials for Prostate Cancer. Some of their research focus areas include:
Stage IV
2Cancer
Global Leader
University Health Network has run 27 trials for Cancer. Some of their research focus areas include:
Stage IV
TP53 positive
HER2 positive

Top PIs

Clinical Trials running at University Health Network

Brain Tumor
Breast Cancer
Prostate Cancer
Cancer
Melanoma
Multiple Myeloma
Thalassemia
Bladder Cancer
Colorectal Cancer
Ovarian Cancer
Image of trial facility.

Liquid Biopsy

for Brain Tumor

Improved outcomes for high-grade gliomas (HGG) require advances in our ability to monitor changes to tumour biology using non-surgical approaches. "Liquid biopsy" is a term used to describe a technique whereby tumour DNA, which has been shed off and then circulates through the blood stream, is detected and analyzed. Our goal is to develop a new type of liquid biopsy that is suitable for primary brain tumours that uses a method that is highly sensitive and allows for ongoing analysis of these tumours.
Recruiting1 award N/A3 criteria
Image of trial facility.

Radiation Therapy

for Brain Cancer

This study will be a dual-arm prospective longitudinal cohort study for patients with brain metastases, at least one of which is appropriate for radiotherapy, to explore brain and cognitive changes following SRS or WBRT and evaluate the feasibility of a novel MRI protocol to identify potential radiological biomarkers of NCF decline. Patients diagnosed with brain mets will be assigned to either Arm A or Arm B, depending on their treatment plan. Patients in Arm A will be treated with SRS. Patients in Arm B will be treated with WBRT. Patients' neurocognitive function will be assessed before their radiation treatment and followed up for 2 years post treatment.
Recruiting1 award N/A10 criteria
Image of trial facility.

Brain Imaging Biomarkers

for Brain Metastases

A biomarker is a measurable indicator of the severity or presence of some disease state. In this study, brain metastases patients who will be receiving radiation treatment, will undergo CT (Computed Tomography) and MRI (Magnetic Resonance Imaging) scans prior to and after radiation treatment to measure these biomarkers. This is a single-center phase II study to validate the predictive abilities of biomarkers, in terms of determining how patients will respond to radiation treatment.
Recruiting1 award Phase 25 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University Health Network?
Where is University Health Network located?
Who should I call to ask about financial aid or insurance network?
What insurance does University Health Network accept?
What awards or recognition has University Health Network received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security